Table 3.
Discriminant function of laboratory tests for benign vs. malignant hepato-pancreato-biliary disease in 213 consecutive patients presented at a specialized multidisciplinary outpatient clinic.
Benign disease (n = 35) |
Malignant disease (n = 178) |
p value | |
---|---|---|---|
IgG4/IgG RNA ratio, % | 4.0 (2.1–6.9) | 3.9 (2.0–8.2) | 0.6 |
IgG4, g/L | 0.4 (0.3–1.1) | 0.5 (0.2–0.9) | 0.6 |
CA 19.9, kU/L | 16.5 (7–50) | 201 (33–1,646) | <0.01 |
Results are presented as medians (IQR); Wilcoxon-Mann-Whitney test.